About Optimus Pharma
Optimus Pharma is a Healthcare company based in Hyderabad (India) founded in 2004, and was acquired by PAG in May 2022. APIs, advanced intermediates, and formulations are manufactured. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Optimus Pharma has raised $11.61 million across 4 funding rounds from investors including Unichem Labs, Srinivasa Rao Venkata Velivela and Kachana Kasturi. The company has 222 employees. Optimus Pharma was last valued at $9.19 million in March 2016. Its Indian entity Optimus Pharma Private Limited reported revenue of ₹81.17 Cr. Optimus Pharma offers products and services including API, Formulations, and Molnupiravir. Its focus areas include Pharmaceuticals, Active Pharmaceutical Ingredients and Formulations. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
Optimus Pharma is involved in the development and manufacturing of Active Pharmaceutical Ingredients (API), intermediates, and finished formulations for global markets. The company operates in the healthcare sector, focusing on research and development with a standalone lab employing over 150 scientists. Solutions are provided through synthetic chemistry, method development, and scale-up activities, ensuring high-quality and affordable products. Operations span across more than 40 countries with a strong emphasis on innovation and manufacturing excellence.
- Headquarters Hyderabad, India
- Employees 222
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website optimuspharma.com
- Social LinkedIn Facebook
- Acquired by PAG (May 2022)
- Legal Name Optimus Pharma Pvt Ltd
- Date of Incorporation 21 Sep, 2004
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹81.17 Cr
FY 2025 · -40% YoY
- Net Loss-₹16.44 Cr
FY 2025 · -20% margin
- EBITDA-₹5.87 Cr
FY 2025 · -7% margin
- Total Equity Funding$11.61M (USD)
in 4 rounds
- Latest Funding Round$9.91M (USD), Series A
Nov 2018
- InvestorsUnichem Labs
& 32 more
- Employee Count222
- Acquired byPAG
(May 2022)
Associated legal entities of Optimus Pharma
Optimus Pharma is associated with 4 registered companies on The Company Check; the primary company is Optimus Pharma Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Optimus Pharma Private Limited CIN U24239TG2004PTC044232 | Active | 21 Sep 2004 | Hyderabad, Telangana | ₹81.2 Cr | 261 | 9 | View details |
| Bay Sands Projects Llp CIN AAV-9929 | Active | 22 Feb 2021 | Hyderabad, Telangana | 2 | View details | ||
| Optimus Life Science Private Limited CIN U24110TG2020PTC139669 | Active | 04 Mar 2020 | Hyderabad, Telangana | ₹0.4 Cr | 13 | 6 | View details |
| Optimus Drugs Private Limited CIN U24239TG2003PTC042155 | Active | 02 Dec 2003 | Hyderabad, Telangana | ₹714 Cr | 895 | 6 | View details |
Products & Services of Optimus Pharma
Optimus Pharma offers a comprehensive portfolio of products and services, including API, Formulations, and Molnupiravir.
Active Pharmaceutical Ingredients are developed for global markets.
Finished formulations are produced for various therapeutic uses.
Antiviral drug is manufactured for emergency use authorization.
Funding Insights of Optimus Pharma
Optimus Pharma has successfully raised a total of $11.61M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $9.91 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.61M
- Total Rounds 4
- Last Round Series A — $9.91M
- First Round $809,014
(Mar 2014)
- Investors Count 32
All 4 funding rounds of Optimus Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $9.91M | Series A | – | Unichem Labs | – |
| Mar 2016 | $754,158 | Angel Round | $9.19M | G Srinivas | |
| Aug 2015 | $143,730 | Angel Round | – | – | – |
| Mar 2014 | $809,014 | Seed | $5.84M | Twine Steel |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2016 | $9.19M | •••••••• |
| Mar 2014 | $5.84M | •••••••• |
Last known valuation $9.19M (Mar 2016). 33 investors in total: 3 institutional and 30 angel.
Investors in Optimus Pharma
Optimus Pharma has secured backing from 33 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Unichem Labs, Srinivasa Rao Venkata Velivela and Kachana Kasturi.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Alternative investment firm | pag.com | |||
Branded formulations, APIs, and biosimilars are manufactured. | 1944 | unichemlabs.com | Mumbai, India | |
Steel products are manufactured by Twine Steel in Kolkata facilities. | Kolkata, India | |||
SR Srinivasa Rao Venkata Velivela | unknown_698a9996d0464d18a | |||
KK Kachana Kasturi | unknown_f155c12bcee84396b | |||
SR Sunkireddy Rajashekar Reddy | unknown_9015609ca3e34e6c9 | |||
VS V Srivani | unknown_d5d75317f9a245b2b | |||
AK Adilakshmi Kata | unknown_39a1a505b36042729 | |||
BP Bhavani Palakonda | unknown_ec60b99c4e9648db9 | |||
RM Ravi Manda | unknown_cd572059dd8d4f6ba |
Investor details for Optimus Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Optimus Pharma Private Limited (Optimus Pharma)
Optimus Pharma Private Limited is the primary company behind Optimus Pharma. The boards of the 4 registered companies of Optimus Pharma currently have 10 directors; the longest-serving is Srinivasareddy Desireddy, appointed in 2021. 45 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasareddy Desireddy DIN 01819852 | Designated Partner | 22 Feb 2021 | 5 yrs 8 mo | Bay Sands Projects Llp, Optimus Drugs Private Limited, Optimus Pharma Private Limited |
| Triveni Reddy Desireddy DIN 02488436 | Designated Partner | 22 Feb 2021 | 5 yrs 8 mo | Bay Sands Projects Llp |
| Durga Prasad Reddy Avula DIN 09740336 | Director | 22 Sep 2022 | 4 yrs 1 mo | Optimus Drugs Private Limited |
| Harsha Vardhana Reddy Poluru DIN 09740319 | Director | 23 Sep 2022 | 4 yrs 1 mo | Optimus Pharma Private Limited |
| Pagadala Baskarannarayanan DIN 09754875 | Director | 19 Oct 2022 | 4 yrs | Optimus Pharma Private Limited, Optimus Life Science Private Limited |
| Anil Khubchandani DIN 09209485 | Director | 26 Jun 2023 | 3 yrs 4 mo | Optimus Pharma Private Limited, Optimus Life Science Private Limited |
| Uma Rao DIN 07810779 | Director | 09 May 2024 | 2 yrs 6 mo | Optimus Drugs Private Limited, Optimus Pharma Private Limited, Optimus Life Science Private Limited |
| Sumit Mohan Nadgir DIN 07619675 | Additional Director | 01 Apr 2025 | 1 yr 7 mo | Optimus Drugs Private Limited, Optimus Pharma Private Limited, Optimus Life Science Private Limited |
| Lakshay Kataria DIN 08345477 | Additional Director | 01 Apr 2025 | 1 yr 7 mo | Optimus Pharma Private Limited, Optimus Life Science Private Limited |
| Santosh Kumar Mahil DIN 07584287 | Additional Director | 26 Jun 2025 | 1 yr 4 mo | Optimus Drugs Private Limited, Optimus Pharma Private Limited, Optimus Life Science Private Limited |
People of Optimus Pharma
7 people are tracked at Optimus Pharma (7 in leadership); the tracked headcount is 222.
| Name | Role | Group |
|---|---|---|
Amadeo Gallego Guerrero | Associate Director Sales & Business Development | Leadership |
D. Srinivasa Reddy | Founder & Managing Director | Leadership |
Vivek Dhar | President, Operations | Leadership |
P. Harsha Vardhana Reddy | Associate Vice President, QMS | Leadership |
Emanuel Jaldi | Head Of Formulations Analytical Research And Development At Optimus Pharma | Leadership |
Srini Optimus | Managing Director | Leadership |
A. Durga Prasad Reddy | Sr.General Manager, Production | Leadership |
Complete people profiles for Optimus Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Optimus Pharma
Figures of Optimus Pharma Private Limited, the primary company behind Optimus Pharma, for FY 2025. Revenue was ₹81.17 Cr (-40% year on year). Net loss was -₹16.44 Cr (-20% margin). EBITDA was -₹5.87 Cr (-7% margin). Revenue has grown at a compounded annual rate of -37% over three years and -6% over five years.
- ₹81.17 CrRevenue · FY 2025 · -40% YoY
- -₹16.44 CrNet loss · -20% margin
- -₹5.87 CrEBITDA · -7% margin
- ₹37.68 CrPaid-up capital
- 261Employees (provident fund records)
- -37%Revenue CAGR, 3 years
- -6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Optimus Pharma Private Limited are on its company page.
Detailed financial statements for Optimus Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Optimus Pharma
5 dated milestones of Optimus Pharma across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Optimus Pharma is founded.
- Funding First funding round of $809K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $9.9M.
- Exit Acquired by PAG.
Competitors of Optimus Pharma
Optimus Pharma has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of Optimus Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Optimus Pharma
The website of Optimus Pharma (optimuspharma.com) receives about 1.7K visits a month and ranks #7,162,653 among all websites worldwide, #6,926 in Biotechnology and Pharmaceuticals.
- Monthly visits1.7K
▼ 3.4% vs previous month
- Global rank#7,162,653
among all websites
- Category rank#6,926
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit2.6
- Average visit2 min 18 sec
- DevicesDesktop 51% · Mobile 49%
Websites whose visitors overlap most with Optimus Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
crystalinks.com | crystalinks.com | 100% | #397,404 | – | |
| optimusinfo.com | 65% | 5.6K | #3,581,863 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Optimus Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Optimus Pharma
Complete news archive for Optimus Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optimus Pharma
Optimus Pharma was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Optimus Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Optimus Pharma is a funded company, having raised a total of $11.61M across 4 funding rounds to date. The company's 1st funding round was a Seed of $809.01K, raised on Mar 2014.
Optimus Pharma has 222 employees.
The primary company behind Optimus Pharma, Optimus Pharma Private Limited, reported revenue of ₹81.17 Cr for FY 2025, down 40% year on year.
Optimus Pharma is involved in the development and manufacturing of Active Pharmaceutical Ingredients (API), intermediates, and finished formulations for global markets. The company operates in the healthcare sector, focusing on research and development with a standalone lab employing over 150 scientists. Solutions are provided through synthetic chemistry, method development, and scale-up activities, ensuring high-quality and affordable products. Operations span across more than 40 countries with a strong emphasis on innovation and manufacturing excellence.
Optimus Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Optimus Pharma offers API, Formulations, and Molnupiravir.
Optimus Pharma has 33 investors. Key investors include Unichem Labs, Srinivasa Rao Venkata Velivela, Kachana Kasturi, Sunkireddy Rajashekar Reddy, and V Srivani.
The valuation of Optimus Pharma is $9.19M as of Mar 2016.
Optimus Pharma is associated with 4 legal entities: Optimus Pharma Private Limited, Bay Sands Projects Llp, Optimus Drugs Private Limited and others.
Yes. Optimus Pharma was acquired by PAG in May 2022.